Clinician's dilemma: Naproxen-induced liver injury

Naproxen is a widely used nonsteroidal anti-inflammatory drug (NSAID) in pediatric population, used for mild-to-moderate pains, arthritis, and other immune-mediated disorders. It rarely causes clinically apparent liver injury in the adult population taking high doses of the drug over a prolonged period and is reported even rarer in pediatric population. We present a case of drug-induced liver injury (DILI) in a 13-year-old girl taking naproxen in therapeutic doses for juvenile rheumatoid arthritis. There was a complete recovery of liver function following discontinuation of naproxen therapy.

[1]  S. Zheng,et al.  Stevens–Johnson syndrome and acute vanishing bile duct syndrome after the use of amoxicillin and naproxen in a child , 2019, The Journal of international medical research.

[2]  D. Kleiner.  Drug-induced Liver Injury: The Hepatic Pathologist's Approach. , 2017, Gastroenterology clinics of North America.

[3]  William M. Lee,et al.  Hepatic Histological Findings in Suspected Drug-Induced Liver Injury: Systematic Evaluation and Clinical Associations , 2013, Hepatology.

[4]  T. Davern.  Drug-induced liver disease. , 2012, Clinics in liver disease.

[5]  Chan K. Ma,et al.  Naproxen-induced liver injury. , 2011, Hepatobiliary & pancreatic diseases international : HBPD INT.